Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Chronic divalproex sodium use and brain atrophy in Alzheimer disease.

Fleisher AS, Truran D, Mai JT, Langbaum JB, Aisen PS, Cummings JL, Jack CR Jr, Weiner MW, Thomas RG, Schneider LS, Tariot PN; Alzheimer's Disease Cooperative Study..

Neurology. 2011 Sep 27;77(13):1263-71. doi: 10.1212/WNL.0b013e318230a16c.

2.

Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease.

Tariot PN, Schneider LS, Cummings J, Thomas RG, Raman R, Jakimovich LJ, Loy R, Bartocci B, Fleisher A, Ismail MS, Porsteinsson A, Weiner M, Jack CR Jr, Thal L, Aisen PS; Alzheimer's Disease Cooperative Study Group..

Arch Gen Psychiatry. 2011 Aug;68(8):853-61. doi: 10.1001/archgenpsychiatry.2011.72.

PMID:
21810649
3.

Divalproex sodium in nursing home residents with possible or probable Alzheimer Disease complicated by agitation: a randomized, controlled trial.

Tariot PN, Raman R, Jakimovich L, Schneider L, Porsteinsson A, Thomas R, Mintzer J, Brenner R, Schafer K, Thal L; Alzheimer's Disease Cooperative Study.; Valproate Nursing Home Study Group..

Am J Geriatr Psychiatry. 2005 Nov;13(11):942-9.

PMID:
16286437
4.

Memantine and brain atrophy in Alzheimer's disease: a 1-year randomized controlled trial.

Wilkinson D, Fox NC, Barkhof F, Phul R, Lemming O, Scheltens P.

J Alzheimers Dis. 2012;29(2):459-69. doi: 10.3233/JAD-2011-111616.

PMID:
22269160
5.

Volumetric MRI and cognitive measures in Alzheimer disease : comparison of markers of progression.

Ridha BH, Anderson VM, Barnes J, Boyes RG, Price SL, Rossor MN, Whitwell JL, Jenkins L, Black RS, Grundman M, Fox NC.

J Neurol. 2008 Apr;255(4):567-74. doi: 10.1007/s00415-008-0750-9.

PMID:
18274807
6.

Effects of Abeta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease.

Fox NC, Black RS, Gilman S, Rossor MN, Griffith SG, Jenkins L, Koller M; AN1792(QS-21)-201 Study..

Neurology. 2005 May 10;64(9):1563-72.

PMID:
15883317
7.

Baseline predictors of rates of hippocampal atrophy in mild cognitive impairment.

van de Pol LA, van der Flier WM, Korf ES, Fox NC, Barkhof F, Scheltens P.

Neurology. 2007 Oct 9;69(15):1491-7.

PMID:
17923611
8.

Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial.

Wilcock GK, Black SE, Hendrix SB, Zavitz KH, Swabb EA, Laughlin MA; Tarenflurbil Phase II Study investigators..

Lancet Neurol. 2008 Jun;7(6):483-93. doi: 10.1016/S1474-4422(08)70090-5. Erratum in: Lancet Neurol. 2011 Apr;10(4):297. Lancet Neurol. 2008 Jul;7(7):575.

PMID:
18450517
9.

A double-blind, randomized, placebo-controlled trial of divalproex extended-release in the treatment of bipolar disorder in children and adolescents.

Wagner KD, Redden L, Kowatch RA, Wilens TE, Segal S, Chang K, Wozniak P, Vigna NV, Abi-Saab W, Saltarelli M.

J Am Acad Child Adolesc Psychiatry. 2009 May;48(5):519-32. doi: 10.1097/CHI.0b013e31819c55ec.

PMID:
19325497
10.

Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.

Freund-Levi Y, Eriksdotter-Jönhagen M, Cederholm T, Basun H, Faxén-Irving G, Garlind A, Vedin I, Vessby B, Wahlund LO, Palmblad J.

Arch Neurol. 2006 Oct;63(10):1402-8.

PMID:
17030655
11.

Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group.

Bowden CL, Brugger AM, Swann AC, Calabrese JR, Janicak PG, Petty F, Dilsaver SC, Davis JM, Rush AJ, Small JG, et al.

JAMA. 1994 Mar 23-30;271(12):918-24. Erratum in: JAMA 1994 Jun 15;271(23):1830.

PMID:
8120960
12.
13.

Placebo-controlled study of divalproex sodium for agitation in dementia.

Porsteinsson AP, Tariot PN, Erb R, Cox C, Smith E, Jakimovich L, Noviasky J, Kowalski N, Holt CJ, Irvine C.

Am J Geriatr Psychiatry. 2001 Winter;9(1):58-66.

PMID:
11156753
14.

Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial.

Smith AD, Smith SM, de Jager CA, Whitbread P, Johnston C, Agacinski G, Oulhaj A, Bradley KM, Jacoby R, Refsum H.

PLoS One. 2010 Sep 8;5(9):e12244. doi: 10.1371/journal.pone.0012244.

15.

Test-retest reliability of memory task functional magnetic resonance imaging in Alzheimer disease clinical trials.

Atri A, O'Brien JL, Sreenivasan A, Rastegar S, Salisbury S, DeLuca AN, O'Keefe KM, LaViolette PS, Rentz DM, Locascio JJ, Sperling RA.

Arch Neurol. 2011 May;68(5):599-606. doi: 10.1001/archneurol.2011.94.

16.

Acute efficacy of divalproex sodium versus placebo in mood stabilizer-naive bipolar I or II depression: a double-blind, randomized, placebo-controlled trial.

Muzina DJ, Gao K, Kemp DE, Khalife S, Ganocy SJ, Chan PK, Serrano MB, Conroy CM, Calabrese JR.

J Clin Psychiatry. 2011 Jun;72(6):813-9. doi: 10.4088/JCP.09m05570gre.

PMID:
20816041
17.

Association of fish oil supplement use with preservation of brain volume and cognitive function.

Daiello LA, Gongvatana A, Dunsiger S, Cohen RA, Ott BR; Alzheimer's Disease Neuroimaging Initiative..

Alzheimers Dement. 2015 Feb;11(2):226-35. doi: 10.1016/j.jalz.2014.02.005.

18.

Double-blind randomized trial of risperidone versus divalproex in pediatric bipolar disorder: fMRI outcomes.

Pavuluri MN, Passarotti AM, Lu LH, Carbray JA, Sweeney JA.

Psychiatry Res. 2011 Jul 30;193(1):28-37. doi: 10.1016/j.pscychresns.2011.01.005.

19.

Entorhinal cortex thickness predicts cognitive decline in Alzheimer's disease.

Velayudhan L, Proitsi P, Westman E, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Spenger C, Hodges A, Powell J, Lovestone S, Simmons A; dNeuroMed Consortium..

J Alzheimers Dis. 2013;33(3):755-66. doi: 10.3233/JAD-2012-121408.

PMID:
23047370
20.

A randomized, placebo-controlled, multicenter study of divalproex sodium extended-release in the acute treatment of mania.

Hirschfeld RM, Bowden CL, Vigna NV, Wozniak P, Collins M.

J Clin Psychiatry. 2010 Apr;71(4):426-32. doi: 10.4088/JCP.08m04960yel.

PMID:
20361904
Items per page

Supplemental Content

Support Center